Tg(Myh6/tetO-Gsk3b*S9A)1Rbns
Transgene Detail
|
Symbol: |
Tg(Myh6/tetO-Gsk3b*S9A)1Rbns |
Name: |
transgene insertion 1, Jeffrey Robbins |
MGI ID: |
MGI:3757954 |
Synonyms: |
MHCminTetO-GSK-CA |
Transgene: |
Tg(Myh6/tetO-Gsk3b*S9A)1Rbns Location: unknown
|
Alliance: |
Tg(Myh6/tetO-Gsk3b*S9A)1Rbns page
|
|
Strain of Origin: |
Not Applicable
|
|
Transgene Type: |
|
Transgenic (Constitutively active, Inducible, Inserted expressed sequence) |
Inducer: |
|
doxycycline/tetracycline |
Mutation: |
|
Insertion
|
|
|
Mutation details: This transgene contains constitutively active Gsk3b (an S9A mutation was introduced to make it constitutively active) under transcriptional control of a minimally active mouse alpha myosin heavy chain (Myh6) promoter fused to seven copies of the tetracycline-responsive promoter element (tetO). To make the Myh6 promoter minimally active, three GATA sites and two thyroid-like response elements are ablated. When bred with transgenic mice expressing a tetracycline transactivator or reverse transactivator protein, cardiac-specific expression of the constitutively active Gsk3b can be controlled by withdrawal or administration of a tetracycline analog.
(J:125131)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:125131 Sanbe A, et al., Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter. Circ Res. 2003 Apr 4;92(6):609-16 |
All: |
1 reference(s) |
|